Effectiveness of Providing Information on Antipsychotic Medication to Patients with Psychotic Disorders: An Integrative Review

References

• Allen, K., Baban, A., Munjiza, J., & Pappa, S. (2019). Management of antipsychotic-related sexual dysfunction: Systematic review. The Journal of Sexual Medicine, 16(12), 1978–1987. https://doi.org/10.1016/j.jsxm.2019.08.022
   PubMed Web of Science ®Google Scholar
• Arthur, D. (2007). A view of the English mental health nursing review from the South East Asian Pacific Rim. International Journal of Nursing Studies, 44(3), 331–333. https://doi.org/10.1016/j.ijnurstu.2007.01.002
   PubMed Web of Science ®Google Scholar
• Begum, F., Mutsatsa, S., Gul, N., Thomas, B., & Flood, C. (2020). Antipsychotic medication side effects knowledge amongst registered mental health nurses in England: A national survey. Journal of Psychiatric and Mental Health Nursing, 27(5), 521–532. https://doi.org/10.1111/jpm.12600
   PubMed Web of Science ®Google Scholar
• Bressington, D., Mui, J., & Gray, R. (2013). Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: A cross sectional study. International Journal of Mental Health Nursing, 22(1), 35–46. https://doi.org/10.1111/j.1447-0349.2012.00830.x
   PubMed Web of Science ®Google Scholar
• Brown, E., & Gray, R. (2015). Tackling medication non-adherence in severe mental illness: Where are we going wrong? Journal of Psychiatric and Mental Health Nursing, 22(3), 192–198. https://doi.org/10.1111/jpm.12186
   PubMed Web of Science ®Google Scholar
• Bäuml, J., Pitschel-Walz, G., Volz, A., Lüscher, S., Rentron, M., & Kissling, W. (2016). Psychoeducation improves compliance and outcome in schizophrenia without an increase of adverse side effects: A 7-year follow-up of the Munich PIP-study. Schizophrenia Bulletin, 42(1), 62–70. https://doi.org/10.1093/schbul/sbw008
   Google Scholar
• Çetin, N., & Aylaz, R. (2018). The effect of mindfulness-based psychoeducation on insight and medication adherence of schizophrenia patient. Archives of Psychiatric Nursing, 32(5), 737–744. https://doi.org/10.1016/j.apnu.2018.04.011
   PubMed Web of Science ®Google Scholar
• Chien, W. T., Mui, J., Gray, R., & Cheung, E. (2016). Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: A randomised controlled trial. BMC Psychiatry, 16(42), 42. https://doi.org/10.1186/s12888-016-0744-6
   PubMedGoogle Scholar
• Choe, K., Sung, B.-J., Kang, Y., & Yoo, S. Y. (2016). Impact of psychoeducation on knowledge of and attitude toward medications in clients with schizophrenia and schizoaffective disorders. Perspectives in Psychiatric Care, 52(2), 113–119. https://doi.org/10.1111/ppc.12106
   PubMed Web of Science ®Google Scholar
• Cuesta, M. J., Sánchez-Torres, A. M., Lorente-Omeñaca, R., Zandio, M., Moreno-Izco, L., & Peralta, V. (2020). Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs). Psychiatry Research, 293, 113404. https://doi.org/10.1016/j.psychres.2020.113404
   PubMed Web of Science ®Google Scholar
• De Hert, M., De Beugher, A., Sweers, K., Wampers, M., Correll, C. U., & Cohen, D. (2016). Knowledge of psychiatric nurses about the potentially lethal side-effects of clozapine. Archives of Psychiatric Nursing, 30(1), 79–83. https://doi.org/10.1016/j.apnu.2015.09.003
   PubMed Web of Science ®Google Scholar
• Dikeç, G., Arabaci, L. A., Uzunoglu, G. B., & Mizrak, D. D. (2018). Metabolic side effects in patients using atypical antipsychotic medications during hospitalization. Journal of Psychosocial Nursing and Mental Health Services, 56(4), 28–37. https://doi.org/10.3928/02793695-20180108-05
   PubMed Web of Science ®Google Scholar
• Dilla, T., Ciudad, A., & Álvarez, M. (2013). Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Patient Preference and Adherence, 7, 275–284. https://doi.org/10.2147/PPA.S41609
   PubMed Web of Science ®Google Scholar
• Hasan, A. A., Callaghan, P., & Lymn, J. (2015). Evaluation of the impact of a psycho-educational intervention for people diagnosed with schizophrenia and their primary caregivers in Jordan: A randomized controlled trial. BMC Psychiatry, 15, 1–10. https://doi.org/10.1186/s12888-015-0444-7
   PubMed Web of Science ®Google Scholar
• Hashimoto, Y., & Tensho, M. (2016). The need for educating patients with schizophrenia about the adverse effects of medications. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists, 24(4), 352–355. https://doi.org/10.1177/1039856216634825
   PubMed Web of Science ®Google Scholar
• Hickling, L. M., Kouvaras, S., Nterian, Z., & Perez-Iglesias, R. (2018). Non-adherence to antipsychotic medication in first-episode psychosis patients. Psychiatry Research, 264, 151–154. https://doi.org/10.1016/j.psychres.2018.04.002
   PubMed Web of Science ®Google Scholar
• Jose, J., & AlHajri, L. (2018). Potential negative impact of informing patients about medication side-effects: A systematic review. International Journal of Clinical Pharmacy, 40(4), 806–822. https://doi.org/10.1007/s11096-018-0716-7
   PubMed Web of Science ®Google Scholar
• Kaar, S. J., Gobjila, C., Butler, E., Henderson, C., & Howes, O. D. (2019). Making decisions about antipsychotics: A qualitative study of patient experiences and the development of a decision aid. BMS Psychiatry, 19, 1–8. https://doi.org/10.1186/s12888-019-2304-3
   PubMed Web of Science ®Google Scholar
• Kohn, L. T., Corrigan, J. M., & Donaldson, M. S. (2000). To err is human. Committee on Quality of Health Care in America, Institute of Medicine National Academy Press.
   Google Scholar
• Lau, K. C., Lee, E. H., Hui, C. L., Chang, W. C., Chan, S. K., & Chen, E. Y. (2015). Psychosis patients’ knowledge, adherence and attitudes towards the naming of antipsychotic medication in Hong Kong. Early Intervention in Psychiatry, 9(5), 422–427. https://doi.org/10.1111/eip.12169
   PubMed Web of Science ®Google Scholar
• Lau, K. C., Lee, E. H., Hui, C. L., Chang, W. C., Chan, S. K., & Chen, E. Y. (2018). Demographic correlates of medication knowledge in Hong Kong early psychosis patients. Early Intervention in Psychiatry, 12(1), 107–112. https://doi.org/10.1111/eip.12351
   PubMed Web of Science ®Google Scholar
• Lee, H., Scolieri, B. B., & Mullick, P. K. (2017). Learned lessons from patients who take clozapine: A case study. Perspectives in Psychiatric Care, 54(4), 457–461. https://doi.org/10.1111/ppc.12245
   PubMed Web of Science ®Google Scholar
• Lorem, G. F., Frafjord, J. S., Steffensen, M., & Wang, C. E. A. (2014). Medication and participation: A qualitative study of patient experiences with antipsychotic drugs. Nursing Ethics, 21(3), 347–358. https://doi.org/10.1177/0969733013498528
   PubMed Web of Science ®Google Scholar
• Matsuda, M., & Kohno, A. (2016). Effects of the nursing psychoeducation program on the acceptance of medication and condition-specific knowledge of patients with schizophrenia. Archives of Psychiatric Nursing, 30(5), 581–586. https://doi.org/10.1016/j.apnu.2016.03.008
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G., PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Morrison, P., Meehan, T., & Stomski, N. J. (2016). Australian mental health staff response to antipsychotic medication side-effects – the perceptions of consumers. Advances in Mental Health, 14(1), 4–13. https://doi.org/10.1080/18387357.2015.1080651
   Web of Science ®Google Scholar
• Nagai, N., Tani, H., Suzuki, T., Ikai, S., Gerretsen, P., Mimura, M., & Uchida, H. (2017). Patients’ knowledge about prescribed antipsychotics and medication adherence in schizophrenia: A cross-sectional survey. Pharmacopsychiatry, 50(6), 264–269. https://doi.org/10.1055/s-0043-113828
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). (2009). Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. https://www.nice.org.uk/guidance/cg76/chapter/1-Guidance#patient-involvement-in-decisions-about-medicines
   Google Scholar
• National Safety and Quality Health Service Standards (NSQH). (2021). Medication safety standard. https://www.safetyandquality.gov.au/standards/nsqhs-standards/medication-safety-standard
   Google Scholar
• Poudel, R. S., Shrestha, S., Prajapati, A., & Piryani, R. (2017). Factors affecting the medication taking behaviour of psychiatric patients: A preliminary study from central Nepal. Journal of Chitwan Medical College, 7(4), 44–50.
   Google Scholar
• Saito, M., Edo, K., Yamamoto, Y., Niwa, S.-I., & Liberman, R. P. (2013). Illness self-management for individuals in acute psychiatric care settings in Japan: Cross-cultural adaptation of an American program. Psychiatric Rehabilitation Journal, 36(4), 272–277. https://doi.org/10.1037/prj0000025
   PubMed Web of Science ®Google Scholar
• Stewart, D. C., Anthony, G. B., & Chesson, R. (2010). ‘It’s not my job. I’m the patient not the doctor’: Patient perspectives on medicines management in the treatment of schizophrenia. Patient Education and Counseling, 78(2), 212–217. https://doi.org/10.1016/j.pec.2009.06.016
   PubMed Web of Science ®Google Scholar
• Stroup, T. S., & Gray, N. (2018). Management of common adverse effects of antipsychotic medications. World Psychiatry: Official Journal of the World Psychiatric Association (WPA), 17(3), 341–356. https://doi.org/10.1002/wps.20567
   PubMed Web of Science ®Google Scholar
• Thana, L. J., O'Connell, L., Carne-Watson, A., Shastri, A., Saravanamuthu, A., Budhwani, N., Jayacodi, S., Leeson, V. C., Munjiza, J., Pappa, S., Hughes, E., Reilly, J., & Crawford, M. J. (2022). Barries to the management of sexual dysfunction among people with psychosis: Analysis of qualitative data from the REMEDY trial. BMC Psychiatry, 22(1), 545. https://doi.org/10.1186/s12888-022-04193-7
   PubMed Web of Science ®Google Scholar
• Tran, T., & Castle, D. (2012). Outcomes from a regular medication programme for consumers with a mental illness. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists, 20(2), 143–147. https://doi.org/10.1177/1039856211432478
   PubMed Web of Science ®Google Scholar
• Whittemore, R., & Knafl, K. (2005). The integrative review: Updated methodology. Journal of Advanced Nursing, 52(5), 546–553. https://doi.org/10.1111/j.1365-2648.2005.03621.x
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2017). Medication Without Harm - Global Patient Safety Challenge on Medication Safety. World Health Organization. Licence: CC BY-NC-SA 3.0 IGO. https://www.who.int/publications/i/item/WHO-HIS-SDS-2017.6
   Google Scholar
• Yeo, S.-U., Park, J.-I., Jang, J.-M., Kang, N.-I., Cui, Y., Kim, M.-G., Kim, H.-M., Jung, A.-J., & Chung, Y.-C. (2017). Acceptance rate of long-acting injection after short information: A survey in patients with first- and multiple-episode psychoses and their caregivers. Early Intervention in Psychiatry, 11(6), 509–516. https://doi.org/10.1111/eip.12262
   PubMed Web of Science ®Google Scholar
• Yanagida, N., Uchino, T., & Uchimura, N. (2017). The effects of psychoeducation on long-term inpatients with schizophrenia and schizoaffective disorder. The Kurume Medical Journal, 63(3.4), 61–67. https://doi.org/10.2739/kurumemedj.MS00011
   PubMedGoogle Scholar
• Zhou, Y., Rosenheck, R., Mohamed, S., Ning, Y., & He, H. (2017). Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge. Psychiatry Research, 250, 129–135. https://doi.org/10.1016/j.psychres.2017.01.036
   PubMed Web of Science ®Google Scholar